Cravath’s New York Office Moves to Two Manhattan West
Christopher K. Fargo represents clients in connection with the tax aspects of mergers and acquisitions, reorganizations, securities offerings and joint ventures. Mr. Fargo has advised on matters across a broad range of industries, including media and entertainment, consumer products, retail, telecommunications, transportation, energy, healthcare and fintech.
His notable transactions include representing:
altafiber in the $670 million sale of CBTS to TowerBrook, its $2.9 billion acquisition by Macquarie Infrastructure, its $650 million combination with Hawaiian Telcom, its $201 million acquisition of OnX Enterprise Solutions and the $361 million carve‑out IPO of CyrusOne as a REIT;
White Mountains Insurance in its $300 million acquisition of a majority stake in Bamboo, its equity investment in Kudu, its $388 million acquisition of NSM Insurance Group and the $1.775 billion sale of NSM to Carlyle, its investment in Elementum Advisors, MediaAlpha’s sale of a significant minority stake to Insignia Capital and its sale of TRANZACT to Clayton Dubilier & Rice;
OUTFRONT Media in the C$410 million divestiture of its Canadian business to Bell Media;
AngloGold Ashanti in its corporate restructuring and change to domicile and primary listing location;
CyrusOne in its $15 billion acquisition by KKR and Global Infrastructure Partners;
Eurazeo in its acquisition of Scaled Agile;
Mr. Fargo has been repeatedly recognized for his work in the tax arena by Chambers USA and The Legal 500 US. In 2017, he was named a “Rising Star” by Law360, recognizing him as one of five outstanding tax lawyers in the nation under the age of 40. In addition, Mr. Fargo has been named a “Leading Lawyer” in international tax by The Legal 500 US and as one of the “500 Leading Dealmakers in America” by Lawdragon. He is a member of the Tax Section of the New York State Bar Association.
Mr. Fargo was born in Boston, Massachusetts. He received a B.A. cum laude from Boston College in 2003 and a J.D. from Columbia Law School in 2006, where he was a Harlan Fiske Stone Scholar.
Mr. Fargo joined Cravath in 2006 and was elected a partner in 2013.
His notable transactions include representing:
altafiber in the $670 million sale of CBTS to TowerBrook, its $2.9 billion acquisition by Macquarie Infrastructure, its $650 million combination with Hawaiian Telcom, its $201 million acquisition of OnX Enterprise Solutions and the $361 million carve‑out IPO of CyrusOne as a REIT;
White Mountains Insurance in its $300 million acquisition of a majority stake in Bamboo, its equity investment in Kudu, its $388 million acquisition of NSM Insurance Group and the $1.775 billion sale of NSM to Carlyle, its investment in Elementum Advisors, MediaAlpha’s sale of a significant minority stake to Insignia Capital and its sale of TRANZACT to Clayton Dubilier & Rice;
OUTFRONT Media in the C$410 million divestiture of its Canadian business to Bell Media;
AngloGold Ashanti in its corporate restructuring and change to domicile and primary listing location;
CyrusOne in its $15 billion acquisition by KKR and Global Infrastructure Partners;
Eurazeo in its acquisition of Scaled Agile;
Mr. Fargo has been repeatedly recognized for his work in the tax arena by Chambers USA and The Legal 500 US. In 2017, he was named a “Rising Star” by Law360, recognizing him as one of five outstanding tax lawyers in the nation under the age of 40. In addition, Mr. Fargo has been named a “Leading Lawyer” in international tax by The Legal 500 US and as one of the “500 Leading Dealmakers in America” by Lawdragon. He is a member of the Tax Section of the New York State Bar Association.
Mr. Fargo was born in Boston, Massachusetts. He received a B.A. cum laude from Boston College in 2003 and a J.D. from Columbia Law School in 2006, where he was a Harlan Fiske Stone Scholar.
Mr. Fargo joined Cravath in 2006 and was elected a partner in 2013.
Chambers USA
Law360
Lawdragon
The Legal 500 US
Deals & Cases
November 18, 2024
Cravath represented Martin Marietta Materials, Inc. in connection with its $1.5 billion registered senior notes offering. Martin Marietta Materials, Inc. is a leading supplier of aggregates and heavy building materials for the construction industry in the United States. The transaction closed on November 4, 2024.
Deals & Cases
November 04, 2024
On November 4, 2024, DRI Healthcare Trust (“the Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced it has acquired a royalty interest in the worldwide net sales of all formulations of sebetralstat, an investigational oral plasma kallikrein inhibitor for the treatment of Hereditary Angioedema, from KalVista Pharmaceuticals ("KalVista") for an aggregate purchase price of up to $179 million, comprised of a $100 million upfront payment, up to $57 million in a sales-based milestone payment and a one-time $22 million optional payment. Additionally, the Trust is making a $5 million investment in KalVista’s common stock in a private placement transaction. Cravath is representing DRI Healthcare Trust in connection with the transaction.
Deals & Cases
October 25, 2024
On October 25, 2024, Legal & General (“L&G”), one of the U.K.’s leading financial services groups and a major global investor, announced its strategic investment in Taurus Investment Holdings, LLC (“Taurus”), a Boston‑based, global real estate private equity firm, alongside an initial commitment of up to $200 million in seed capital to multifamily real estate. Cravath is representing L&G in connection with the transaction.
Deals & Cases
October 04, 2024
On October 3, 2024, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, announced that one of its wholly owned subsidiaries acquired a portion of Editas Medicine, Inc.'s payment rights under a non‑exclusive license of Editas' Cas9 gene‑editing technology for CASGEVY®, the only approved gene‑edited cell therapy for sickle cell disease and transfusion‑dependent beta thalassemia, for an upfront purchase price of $57 million. The transaction entitles DRI Healthcare to specific payments based on a sublicensing agreement between Editas and Vertex Pharmaceuticals Incorporated. The payments include a share of the annual license fees that Vertex pays to Editas, which can range from $5 million to $40 million, including certain sales‑based annual license fee increases, and a portion of a $50 million contingent payment to which Editas is eligible under the Vertex sublicensing agreement. Cravath is representing DRI Healthcare in connection with the transaction.
Deals & Cases
September 24, 2024
Cravath represented AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust in connection with its $2.4 billion registered senior notes offering. AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust are wholly owned subsidiaries of AerCap Holdings N.V., the world’s largest independent aircraft leasing company. The transaction closed on September 10, 2024.
Publications
December 19, 2024
On December 18, 2024, Cravath prepared a memo for its clients entitled “IRS and Treasury Publish Final Regulations for Section 48 Investment Tax Credits.” The memo examines the U.S. Department of the Treasury and the Internal Revenue Service’s recently published final regulations regarding the energy credit available under Section 48 of the Internal Revenue Code.
Publications
November 19, 2024
On November 19, 2024, Cravath prepared a memo for its clients entitled “IRS and Treasury Publish Final Regulations for Advanced Manufacturing Production Tax Credits.” The memo examines the United States Department of the Treasury and the Internal Revenue Service’s recently issued final regulations for Advanced Manufacturing Production Tax Credits under Section 45X of the Internal Revenue Code.
Publications
April 30, 2024
On April 26, 2024, Cravath prepared a discussion of the recent final regulations on the qualification of REITs as “domestically controlled,” a common planning point for foreign investors in US real estate.
Publications
February 14, 2024
Cravath partners G.J. Ligelis Jr., Alyssa K. Caples, Christopher K. Fargo and Margaret T. Segall co‑authored the U.S. Law & Practice chapter of the fourth edition of Chambers “Investing In… 2024” Guide, which was published in January 2024. The guide, which is part of the publisher’s Global Practice Guides series, examines country‑specific legal issues that arise from foreign direct investment (“FDI”) and cross‑border transactions in the more than 30 jurisdictions covered. The U.S. Law & Practice chapter surveys the legal system and regulatory framework for FDI in the country, analyzing the economic climate, as well as considerations related to mergers and acquisitions, corporate governance, capital markets, antitrust, national security, tax, employment and intellectual property.
Publications
March 03, 2023
Cravath partners G.J. Ligelis Jr., Alyssa K. Caples, Christopher K. Fargo and Margaret T. Segall co-authored the U.S. Law & Practice chapter of the third edition of Chambers “Investing In… 2023” Guide, which was published in January 2023. The guide, which is part of the publisher’s Global Practice Guides series, examines country specific legal issues that arise from foreign direct investment (“FDI”) and cross border transactions in the 33 jurisdictions covered. The U.S. Law & Practice chapter surveys the legal system and regulatory framework for FDI in the country, analyzing the economic climate, as well as considerations related to mergers and acquisitions, corporate governance, capital markets, antitrust, national security, tax, employment and intellectual property.
Christopher K. Fargo represents clients in connection with the tax aspects of mergers and acquisitions, reorganizations, securities offerings and joint ventures. Mr. Fargo has advised on matters across a broad range of industries, including media and entertainment, consumer products, retail, telecommunications, transportation, energy, healthcare and fintech.
His notable transactions include representing:
altafiber in the $670 million sale of CBTS to TowerBrook, its $2.9 billion acquisition by Macquarie Infrastructure, its $650 million combination with Hawaiian Telcom, its $201 million acquisition of OnX Enterprise Solutions and the $361 million carve‑out IPO of CyrusOne as a REIT;
White Mountains Insurance in its $300 million acquisition of a majority stake in Bamboo, its equity investment in Kudu, its $388 million acquisition of NSM Insurance Group and the $1.775 billion sale of NSM to Carlyle, its investment in Elementum Advisors, MediaAlpha’s sale of a significant minority stake to Insignia Capital and its sale of TRANZACT to Clayton Dubilier & Rice;
OUTFRONT Media in the C$410 million divestiture of its Canadian business to Bell Media;
AngloGold Ashanti in its corporate restructuring and change to domicile and primary listing location;
CyrusOne in its $15 billion acquisition by KKR and Global Infrastructure Partners;
Eurazeo in its acquisition of Scaled Agile;
Mr. Fargo has been repeatedly recognized for his work in the tax arena by Chambers USA and The Legal 500 US. In 2017, he was named a “Rising Star” by Law360, recognizing him as one of five outstanding tax lawyers in the nation under the age of 40. In addition, Mr. Fargo has been named a “Leading Lawyer” in international tax by The Legal 500 US and as one of the “500 Leading Dealmakers in America” by Lawdragon. He is a member of the Tax Section of the New York State Bar Association.
Mr. Fargo was born in Boston, Massachusetts. He received a B.A. cum laude from Boston College in 2003 and a J.D. from Columbia Law School in 2006, where he was a Harlan Fiske Stone Scholar.
Mr. Fargo joined Cravath in 2006 and was elected a partner in 2013.
His notable transactions include representing:
altafiber in the $670 million sale of CBTS to TowerBrook, its $2.9 billion acquisition by Macquarie Infrastructure, its $650 million combination with Hawaiian Telcom, its $201 million acquisition of OnX Enterprise Solutions and the $361 million carve‑out IPO of CyrusOne as a REIT;
White Mountains Insurance in its $300 million acquisition of a majority stake in Bamboo, its equity investment in Kudu, its $388 million acquisition of NSM Insurance Group and the $1.775 billion sale of NSM to Carlyle, its investment in Elementum Advisors, MediaAlpha’s sale of a significant minority stake to Insignia Capital and its sale of TRANZACT to Clayton Dubilier & Rice;
OUTFRONT Media in the C$410 million divestiture of its Canadian business to Bell Media;
AngloGold Ashanti in its corporate restructuring and change to domicile and primary listing location;
CyrusOne in its $15 billion acquisition by KKR and Global Infrastructure Partners;
Eurazeo in its acquisition of Scaled Agile;
Mr. Fargo has been repeatedly recognized for his work in the tax arena by Chambers USA and The Legal 500 US. In 2017, he was named a “Rising Star” by Law360, recognizing him as one of five outstanding tax lawyers in the nation under the age of 40. In addition, Mr. Fargo has been named a “Leading Lawyer” in international tax by The Legal 500 US and as one of the “500 Leading Dealmakers in America” by Lawdragon. He is a member of the Tax Section of the New York State Bar Association.
Mr. Fargo was born in Boston, Massachusetts. He received a B.A. cum laude from Boston College in 2003 and a J.D. from Columbia Law School in 2006, where he was a Harlan Fiske Stone Scholar.
Mr. Fargo joined Cravath in 2006 and was elected a partner in 2013.
Chambers USA
Law360
Lawdragon
The Legal 500 US
Deals & Cases
November 18, 2024
Cravath represented Martin Marietta Materials, Inc. in connection with its $1.5 billion registered senior notes offering. Martin Marietta Materials, Inc. is a leading supplier of aggregates and heavy building materials for the construction industry in the United States. The transaction closed on November 4, 2024.
Deals & Cases
November 04, 2024
On November 4, 2024, DRI Healthcare Trust (“the Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced it has acquired a royalty interest in the worldwide net sales of all formulations of sebetralstat, an investigational oral plasma kallikrein inhibitor for the treatment of Hereditary Angioedema, from KalVista Pharmaceuticals ("KalVista") for an aggregate purchase price of up to $179 million, comprised of a $100 million upfront payment, up to $57 million in a sales-based milestone payment and a one-time $22 million optional payment. Additionally, the Trust is making a $5 million investment in KalVista’s common stock in a private placement transaction. Cravath is representing DRI Healthcare Trust in connection with the transaction.
Deals & Cases
October 25, 2024
On October 25, 2024, Legal & General (“L&G”), one of the U.K.’s leading financial services groups and a major global investor, announced its strategic investment in Taurus Investment Holdings, LLC (“Taurus”), a Boston‑based, global real estate private equity firm, alongside an initial commitment of up to $200 million in seed capital to multifamily real estate. Cravath is representing L&G in connection with the transaction.
Deals & Cases
October 04, 2024
On October 3, 2024, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, announced that one of its wholly owned subsidiaries acquired a portion of Editas Medicine, Inc.'s payment rights under a non‑exclusive license of Editas' Cas9 gene‑editing technology for CASGEVY®, the only approved gene‑edited cell therapy for sickle cell disease and transfusion‑dependent beta thalassemia, for an upfront purchase price of $57 million. The transaction entitles DRI Healthcare to specific payments based on a sublicensing agreement between Editas and Vertex Pharmaceuticals Incorporated. The payments include a share of the annual license fees that Vertex pays to Editas, which can range from $5 million to $40 million, including certain sales‑based annual license fee increases, and a portion of a $50 million contingent payment to which Editas is eligible under the Vertex sublicensing agreement. Cravath is representing DRI Healthcare in connection with the transaction.
Deals & Cases
September 24, 2024
Cravath represented AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust in connection with its $2.4 billion registered senior notes offering. AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust are wholly owned subsidiaries of AerCap Holdings N.V., the world’s largest independent aircraft leasing company. The transaction closed on September 10, 2024.
Publications
December 19, 2024
On December 18, 2024, Cravath prepared a memo for its clients entitled “IRS and Treasury Publish Final Regulations for Section 48 Investment Tax Credits.” The memo examines the U.S. Department of the Treasury and the Internal Revenue Service’s recently published final regulations regarding the energy credit available under Section 48 of the Internal Revenue Code.
Publications
November 19, 2024
On November 19, 2024, Cravath prepared a memo for its clients entitled “IRS and Treasury Publish Final Regulations for Advanced Manufacturing Production Tax Credits.” The memo examines the United States Department of the Treasury and the Internal Revenue Service’s recently issued final regulations for Advanced Manufacturing Production Tax Credits under Section 45X of the Internal Revenue Code.
Publications
April 30, 2024
On April 26, 2024, Cravath prepared a discussion of the recent final regulations on the qualification of REITs as “domestically controlled,” a common planning point for foreign investors in US real estate.
Publications
February 14, 2024
Cravath partners G.J. Ligelis Jr., Alyssa K. Caples, Christopher K. Fargo and Margaret T. Segall co‑authored the U.S. Law & Practice chapter of the fourth edition of Chambers “Investing In… 2024” Guide, which was published in January 2024. The guide, which is part of the publisher’s Global Practice Guides series, examines country‑specific legal issues that arise from foreign direct investment (“FDI”) and cross‑border transactions in the more than 30 jurisdictions covered. The U.S. Law & Practice chapter surveys the legal system and regulatory framework for FDI in the country, analyzing the economic climate, as well as considerations related to mergers and acquisitions, corporate governance, capital markets, antitrust, national security, tax, employment and intellectual property.
Publications
March 03, 2023
Cravath partners G.J. Ligelis Jr., Alyssa K. Caples, Christopher K. Fargo and Margaret T. Segall co-authored the U.S. Law & Practice chapter of the third edition of Chambers “Investing In… 2023” Guide, which was published in January 2023. The guide, which is part of the publisher’s Global Practice Guides series, examines country specific legal issues that arise from foreign direct investment (“FDI”) and cross border transactions in the 33 jurisdictions covered. The U.S. Law & Practice chapter surveys the legal system and regulatory framework for FDI in the country, analyzing the economic climate, as well as considerations related to mergers and acquisitions, corporate governance, capital markets, antitrust, national security, tax, employment and intellectual property.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.